Paul Hastings (Nkarta)
‘You have to get up on the podium’: Incoming BIO chair Paul Hastings on diversity, drug pricing and working with the FDA
Paul Hastings’ day job as CEO of Nkarta has him talking about natural killer cells and their potential applications in cancer. But throughout the pandemic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.